Month: September 2015

COST OF DIABETES MELLITUS – IS EARLY DIAGNOSIS A SAVIOR?

Accra, Ghana – The number of diabetes cases and the associated health care budget has been increasing worldwide. It has thus become a growing public health burden for patients, health care providers, and society. The cost of diabetes study has

Posted in Health Policy Analyses, ISPOR News & Press, Value in Health Regional Issues Tagged with: , , , , ,

GENERATING EQ-5D-5L HEALTH STATE VALUES IN THE UAE

Abu Dhabi, UAE – Evidence on the health-related quality of life of patients is increasingly being requested by payers in the Middle East. Yet, no EQ-5D-5L value sets are currently available to inform decision making in the region’s health care

Posted in ISPOR News & Press, Preference-Based Assessments, Value in Health Regional Issues Tagged with:

DECONSTRUCTING PHARMACEUTICAL TENDERING: UNDERSTANDING THE UNDERLYING ELEMENTS

Latsia, Cyprus – Tendering is an aggressive pricing and reimbursement tool with proven potency in the pharmaceutical sector.  The pharmaceutical sector is exhibiting high annual sales-increase rates; therefore, the need for optimized, potent, and sustainable pricing and reimbursement tools is

Posted in Health Policy Analyses, ISPOR News & Press, Value in Health Regional Issues Tagged with: , , , , , ,

ISPOR EXPANDS SCIENTIFIC STAFF BY ADDITION OF CHIEF SCIENCE OFFICER

Princeton, NJ, USA – The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is pleased to announce it is recruiting for a Senior Director & Chief Science Officer, a new position reporting to the Chief Executive Officer & Executive Director.  This

Posted in Announcements, ISPOR News & Press Tagged with: ,